Systematic review and meta-analysis of the clinical features of MGRS
Abstract Background It is crucial to identify patients with monoclonal gammopathy of renal significance (MGRS) from those without MGRS but with monoclonal gammopathy and concomitant kidney diseases. However, there have been few studies with large sample sizes, and their findings were inconsistent. T...
Main Authors: | Jingxue Du, Zhangxue Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12882-024-03458-5 |
Similar Items
-
Clinicopathological characteristics and prognosis in patients with monoclonal gammopathy and renal damage in central China: a multicenter retrospective cohort study
by: Huimin He, et al.
Published: (2024-04-01) -
Assessment of current clinical practice throughout the UK for the diagnosis and management of monoclonal gammopathy of renal significance
by: Satarupa Choudhuri, et al.
Published: (2023-05-01) -
Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment
by: Artem Oganesyan, et al.
Published: (2022-11-01) -
C3 Glomerulonephritis Associated with Monoclonal Gammopathy of Renal Significance
by: Inês Gomes-Alves, et al.
Published: (2021-05-01) -
Editorial: Monoclonal gammopathies of clinical significance: Clinical and therapeutic implications
by: Chen Wang, et al.
Published: (2023-01-01)